Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 17 of 17 entries
View as:

Clinical Trial Phase I/II Prospective, Open Nonrandomized for Treatmen of Postoperative Air Leak After Lung Resection in High Risk Patients Through the Administration of Mesenchymal Autologous Cells

Phase: N/A Priority: Normal
NCT ID: NCT02045745 Org: User:
Start: 12/31/13 End: 12/31/17 Due: 12/31/18

Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT02286011 Org: User:
Start: 11/30/14 End: 12/31/17 Due: 12/31/18

PHASE II CLINICAL TRIAL Prospective, Open, Nonrandomized Treatment of Osteonecrosis of the Femoral Head by the Administration of Autologous Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT01700920 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa

Phase: N/A Priority: Normal
NCT ID: NCT02280135 Org: User:
Start: 11/30/14 End: 03/31/17 Due: 03/31/18

Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)

Phase: N/A Priority: Normal
NCT ID: NCT01860417 Org: User:
Start: 06/21/13 End: 12/15/15 Due: 12/15/16

Clinical Trial Based on the Use of Mesenchymal Stem Cells From Autologous Bone Marrow in Patients With Lumbar Intervertebral Degenerative Disc Disease

Phase: N/A Priority: Normal
NCT ID: NCT01513694 Org: User:
Start: 01/31/10 End: 05/04/17 Due: 05/04/18

Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT01183728 Org: User:
Start: 05/31/10 End: 09/30/14 Due: 09/30/15

Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

Phase: N/A Priority: Normal
NCT ID: NCT01824368 Org: User:
Start: 04/30/13 End: 04/30/16 Due: 04/30/17

Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT01586312 Org: User:
Start: 04/30/12 End: 06/30/14 Due: 06/30/15

Clinical Trial of Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients With Osteonecrosis

Phase: N/A Priority: Normal
NCT ID: NCT02566681 Org: User:
Start: 09/30/15 End: 12/31/18 Due: 12/31/19

Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H)

Phase: N/A Priority: Normal
NCT ID: NCT01389661 Org: User:
Start: 04/30/11 End: 04/25/16 Due: 04/25/17

Use of the Amniotic Membrane in Large Wound Epithelialization

Phase: N/A Priority: Normal
NCT ID: NCT01824381 Org: User:
Start: 07/31/12 End: 03/31/17 Due: 03/31/18

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT03673748 Org: User:
Start: 12/27/22 End: 07/31/26 Due: 07/31/27

Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)

Phase: N/A Priority: Normal
NCT ID: NCT02440074 Org: User:
Start: 06/30/11 End: 12/31/12 Due: 12/31/13

Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stem Cells

Phase: N/A Priority: Normal
NCT ID: NCT04361942 Org: User:
Start: 05/01/20 End: 10/28/21 Due: 10/28/22

Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro

Phase: N/A Priority: Normal
NCT ID: NCT02104440 Org: User:
Start: 10/31/13 End: 03/31/17 Due: 03/31/18

Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT02566655 Org: User:
Start: 09/30/15 End: 05/31/18 Due: 05/31/19